ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs prnasia
January 19, 2021Hanmi Pharmaceutical Co., Ltd. plans to create a global R&D achievement based on innovations of inflammation–fibrosis treatment, Triple-acting new drug for NASH (non-alcoholic steatohepatitis) treatment as well as various other innovations in ...
Pharma Sources Insight January 2025
